I-SPY 2 Breast Cancer Clinical Trial Launches Nationwide

被引：2
|
作者：
不详
机构：
来源：
CANCER | 2010年 / 116卷 / 14期
关键词：
D O I：
10.1002/cncr.25494
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3308 / 3308
页数：1
相关论文
共 50 条
  • [1] I-SPY a revolutionary breast cancer clinical trial
    不详
    [J]. BIOANALYSIS, 2010, 2 (05) : 939 - 939
  • [2] I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
    Barker, A. D.
    Sigman, C. C.
    Kelloff, G. J.
    Hylton, N. M.
    Berry, D. A.
    Esserman, L. J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (01) : 97 - 100
  • [3] I-SPY 2 Breast Cancer Trial as a Model for Innovation in Alzheimer Disease Therapies
    Messmer, Mindi F.
    Wilhelm, Erin E.
    Shoulson, Ira
    [J]. JAMA NEUROLOGY, 2017, 74 (09) : 1027 - +
  • [4] I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast Cancer
    Wang, Haiyun
    Yee, Douglas
    [J]. CURRENT BREAST CANCER REPORTS, 2019, 11 (04) : 303 - 310
  • [5] I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast Cancer
    Haiyun Wang
    Douglas Yee
    [J]. Current Breast Cancer Reports, 2019, 11 : 303 - 310
  • [6] Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trial
    Wolf, Denise M.
    Yau, Christina
    Wulfkuhle, Julia
    Brown-Swigart, Lamorna
    Gallagher, Rosa I.
    Jesus M. Magbanua, Mark
    O'Grady, Nick
    Hirst, Gillian
    Asare, Smita
    Tripathy, Debu
    Berry, Don
    Esserman, Laura
    Chien, A. Jo
    Petricoin, Emanuel F., III
    van't Veer, Laura
    [J]. NPJ BREAST CANCER, 2020, 6 (01)
  • [7] Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trial
    Denise M. Wolf
    Christina Yau
    Julia Wulfkuhle
    Lamorna Brown-Swigart
    Rosa I. Gallagher
    Mark Jesus M. Magbanua
    Nick O’Grady
    Gillian Hirst
    Smita Asare
    Debu Tripathy
    Don Berry
    Laura Esserman
    A. Jo Chien
    Emanuel F. Petricoin
    Laura van ‘t Veer
    [J]. npj Breast Cancer, 6
  • [8] I-SPY 2 Clinical Trial: Telephone Support Provided by Peer Counselors
    Perlmutter, J.
    Parker, B.
    Nixon, N.
    Esserman, L.
    [J]. CANCER RESEARCH, 2010, 70
  • [9] Identification of symptoms that are associated with irAEs in the I-SPY clinical trial
    Basu, Amrita
    Umashankar, Saumya
    Melisko, Michelle
    Lu, Ruixiao
    Yu, Hongmei
    Yau, Christina
    Asare, Smita
    Pitsouni, Maria
    Shatsky, Rebecca A.
    Isaacs, Claudine
    DeMichele, Angela
    Hershman, Dawn
    Nanda, Rita
    Kim, Mi-Ok
    Esserman, Laura J.
    Rugo, Hope
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [10] Rationale of the design of the I-SPY trial
    DeMichele, A.
    Yee, D.
    Hylton, N.
    Vant'Veer, L.
    Symmons, W. F.
    Perlmutter, J.
    Lyandres, J.
    Davis, S.
    Buxton, M.
    Berry, D.
    Esserman, L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S2 - S2
12345